Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D002675:Child, Preschool; D003168:Complement Fixation Tests; D046508:Culture Techniques; D004196:Disease Outbreaks; D004219:District of Columbia; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008722:Methods; D009976:Orthomyxoviridae Infections / Q000276:immunology* / Q000517:prevention & control; D011159:Population Surveillance; D012111:Residence Characteristics; D012136:Respiratory Syncytial Viruses / Q000276:immunology* / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000276:immunology*; D018108:Respirovirus / Q000276:immunology; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000009:adverse effects*
D000906:Antibodies; D014765:Viral Vaccines